Novonesis Expects Results From Weight-loss Drug Supplement Study in 2027

Published Date: 21 Aug 2026

Danish biosolutions maker Novonesis expects results in the second half of 2027 from research ⁠with Novo Nordisk into whether microbiome supplements could provide additional...

Read Full News

Latest News

Soccer-Spanish FA Launches Fertility Support Programme for Female Players and Referees

Spain's football federation has unveiled an agreement to support fertility treatment for female players and referees, presenting the measure as another way to give women in...

Midwifery Goes Beyond Birth: What Is Still Overlooked?

Midwives’ roles extend across reproductive, pregnancy, postpartum, pelvic floor, and community care, but cultural, structural, and professional barriers can limit their practice.

Ultrasound May Help Predict Graves Orbitopathy Risk

Researchers test a new risk score using ultrasound to screen for orbitopathy, a complication estimated to occur in more than 25% of people with Graves disease.

RET Fusion Linked to Occult Lymph Node Metastasis in PTC

A machine learning model uses independent risk factors to identify occult lymph node metastasis in clinically lymph node negative papillary thyroid cancer.

Tirzepatide Beats Semaglutide for Weight Loss, Not Safety

Tirzepatide may provide greater weight loss than semaglutide in adults with overweight or obesity, but this advantage comes at the cost of a higher risk for serious adverse events.

More Children Under 12 in US Are Being Prescribed Weight-loss Drugs, Study Finds

Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors ⁠seek new, effective treatments for younger...

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

Spain's football federation has unveiled an agreement to support fertility treatment for female players and referees, presenting the measure as another way to give women in...

Midwives’ roles extend across reproductive, pregnancy, postpartum, pelvic floor, and community care, but cultural, structural, and professional barriers can limit their practice.

Researchers test a new risk score using ultrasound to screen for orbitopathy, a complication estimated to occur in more than 25% of people with Graves disease.

A machine learning model uses independent risk factors to identify occult lymph node metastasis in clinically lymph node negative papillary thyroid cancer.

Tirzepatide may provide greater weight loss than semaglutide in adults with overweight or obesity, but this advantage comes at the cost of a higher risk for serious adverse events.

Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors ⁠seek new, effective treatments for younger...

News All Time

Keto Diet Outperforms Others in Liver Health in Obesity

Liver health improves more on a very-low-carbohydrate ketogenic diet than on a Mediterranean or very-low-fat plant-forward diet.

Earlier SGLT2 Use After AKI May Improve Outcomes

Earlier SGLT2 inhibitor use after dialysis-requiring AKI is linked to better kidney outcomes in patients with type 2 diabetes, with no increase in safety events.

From Hunger to Obesity: Developing World Faces Growing Threat to Child Health

Intan Permatasari's mother simply couldn't refuse her daughter's pleas for food. By the time she was 4, Intan had outgrown all the kindergarten uniforms and had to wear...

US Pentagon Issues Clinical Guidelines on Troop Testosterone Screening to Start Immediately

The U.S. Pentagon issued detailed guidance on Wednesday for a new, mandatory testosterone deficiency screening policy ⁠for active-duty and reserve service members age 30 and...

New Tool Helps Clinicians Screen for Obesity’s Causes

Experts have developed a new 25-minute tool to screen patients for over 30 possible causes of obesity, from genetics to psychological trauma.

Too Weak, Too Strict: India's Food Warning Labels Draw Fire From All Sides

The Indian government is facing fierce opposition on proposed food warning labels from both health experts and food giants - activists say many items will escape scrutiny...

Early Childhood Obesity Linked to Adolescent Obesity Risk

Obesity during early childhood is strongly linked to obesity by adolescence, whereas overweight carries a far smaller risk for progression — even after a recent BMI rise from normal weight.

Hims & Hers Offers GLP-1s, Men's Health Treatments in Australia

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

600,000 Seniors Have Signed Up for Obesity Drugs Under New Medicare Program

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

GLP-1 Weight Loss Drugs Effective Even At Low Starter Doses

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Time-Restricted Eating Helps Sustain Weight Loss

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Contraceptives Affect Steroid Profiles in Females With CAH

Combined oral contraceptives reduce plasma and urinary androgen levels and increase total cortisol levels in adolescent and young females with congenital adrenal hyperplasia.

Thyroid Shifts in Midlife Women? Blame Aging, Not Menopause

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

Thyroid Hormone Receptor Beta Agonist Cuts Liver Fat in MASH

A selective thyroid hormone receptor beta agonist demonstrates dose-dependent reductions in hepatic fat among adults with metabolic dysfunction-associated steatohepatitis in a phase 2 trial.